临床肺科杂志
臨床肺科雜誌
림상폐과잡지
JOUNAL OF CLINICAL PULMONARY MEDICINE
2014年
12期
2261-2262
,共2页
苏黄止咳胶囊%布地奈德福莫特罗粉吸入剂%咳嗽变异性哮喘
囌黃止咳膠囊%佈地奈德福莫特囉粉吸入劑%咳嗽變異性哮喘
소황지해효낭%포지내덕복막특라분흡입제%해수변이성효천
Suhuangzhike capsule%budesonide and formoterol fumarate powder for inhalation%cough variant asthma
目的:观察苏黄止咳胶囊联合信必可都保(布地奈德福莫特罗粉吸入剂)治疗咳嗽变异性哮喘( CVA)的治疗效果。方法将80例诊断为咳嗽变异型哮喘的患者随机分成甲乙两组。甲组:布地奈德福莫特罗粉吸入剂(1吸/次,2次/d);乙组:予以苏黄止咳胶囊(3粒/次,3次/d)联合布地奈德福莫特罗粉吸入剂(1吸/次,2次/d )。观察治疗1周后患者咳嗽症状及治疗1个月后肺功能改善状况。结果与甲组相比,乙组治疗1周后咳嗽症状及治疗1个月后肺功能明显好转( P<0.05)。结论采用苏黄止咳胶囊联合布地奈德福莫特罗粉吸入剂治疗咳嗽变异性哮喘的治疗效果更好,值得临床推广。
目的:觀察囌黃止咳膠囊聯閤信必可都保(佈地奈德福莫特囉粉吸入劑)治療咳嗽變異性哮喘( CVA)的治療效果。方法將80例診斷為咳嗽變異型哮喘的患者隨機分成甲乙兩組。甲組:佈地奈德福莫特囉粉吸入劑(1吸/次,2次/d);乙組:予以囌黃止咳膠囊(3粒/次,3次/d)聯閤佈地奈德福莫特囉粉吸入劑(1吸/次,2次/d )。觀察治療1週後患者咳嗽癥狀及治療1箇月後肺功能改善狀況。結果與甲組相比,乙組治療1週後咳嗽癥狀及治療1箇月後肺功能明顯好轉( P<0.05)。結論採用囌黃止咳膠囊聯閤佈地奈德福莫特囉粉吸入劑治療咳嗽變異性哮喘的治療效果更好,值得臨床推廣。
목적:관찰소황지해효낭연합신필가도보(포지내덕복막특라분흡입제)치료해수변이성효천( CVA)적치료효과。방법장80례진단위해수변이형효천적환자수궤분성갑을량조。갑조:포지내덕복막특라분흡입제(1흡/차,2차/d);을조:여이소황지해효낭(3립/차,3차/d)연합포지내덕복막특라분흡입제(1흡/차,2차/d )。관찰치료1주후환자해수증상급치료1개월후폐공능개선상황。결과여갑조상비,을조치료1주후해수증상급치료1개월후폐공능명현호전( P<0.05)。결론채용소황지해효낭연합포지내덕복막특라분흡입제치료해수변이성효천적치료효과경호,치득림상추엄。
Objective To observe the curative effect of Suhuangzhike capsule combined with symbicort tur-buhaler ( budesonide and formoterol fumarate powder) in the treatment of cough variant asthma ( CVA) . Methods 80 patients with cough variant asthma were randomly divided into two groups. The group A was given budesonide and formoterol fumarate powder for inhalation (1 suction per time, 2 times per day), and the group B was given Suhuang-zhike capsule (3 capsules each time, 3 times per day) combined with budesonide and formoterol fumarate powder for inhalation (1 suction per time, 2 times per day). The symptoms of cough and pulmonary function were observed 1 week and 1 month after the treatment. Results After the treatment, the improvement of pulmonary function was more pronounced in the group B than in the group A (P<0. 05). Conclusion Suhuangzhike capsule combined with budesonide and formoterol fumarate powder for inhalation has better curative effect in the treatment of cough variant asthma.